ArticleOncoTargets and therapy2021

Efficacy and Drug Resistance Analysis of ALK Inhibitors in Combination with Stereotactic Body Radiation Therapy for Treating Lung Squamous Carcinoma Patient Harboring EML4-ALK Rearrangement.

Long Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.